S18-081 Therapeutic to restore vision loss Researchers at Stanford have developed a new therapeutic to promote survival of retinal ganglion cells (RGCs) and optic nerve regeneration after traumatic injury or optic neuropathies. Michael Kapiloff Jeffrey Goldberg